Colchicine's Potential in Reducing Cardiovascular Risks: Emerging Evidence and Clinical Implications

Colchicine, an anti-inflammatory drug, has shown promise in reducing the risk of major adverse cardiovascular events (MACE) in patients with established atherosclerotic disease or multiple cardiovascular risk factors.